Annexin presents at ProHearings on August 29
Annexin Pharmaceuticals AB today announced that the company is participating at ProHearings’ Capital Markets Day on August 29, 2023, at 09:10 CET. CEO Anders Haegerstrand will present the latest development of the company, including the recently presented promising signals of effect in the company’s ongoing clinical RVO-study. The presentation and moderated Q&A session is broadcasted live via organizer’s website www.prohearings.com, where registration for in-person attendance at the venue in central Stockholm also is available. The presentation will also be available at Annexin’s website